Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$0.53 - $0.93 $144,637 - $253,797
272,901 Added 894.79%
303,400 $175,000
Q4 2023

Feb 12, 2024

SELL
$0.63 - $1.14 $119,144 - $215,595
-189,119 Reduced 86.11%
30,499 $25,000
Q3 2023

Nov 14, 2023

SELL
$1.12 - $1.88 $1,901 - $3,192
-1,698 Reduced 0.77%
219,618 $248,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $14,337 - $22,327
-10,945 Reduced 4.71%
221,316 $354,000
Q1 2023

May 15, 2023

SELL
$1.45 - $2.95 $33,969 - $69,109
-23,427 Reduced 9.16%
232,261 $353,000
Q4 2022

Feb 14, 2023

BUY
$2.02 - $3.25 $34,325 - $55,227
16,993 Added 7.12%
255,688 $613,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $23,396 - $37,482
11,937 Added 5.26%
238,695 $489,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $39,314 - $79,838
-30,242 Reduced 11.77%
226,758 $440,000
Q3 2021

Nov 12, 2021

BUY
$4.98 - $6.63 $296,310 - $394,485
59,500 Added 30.13%
257,000 $1.35 Million
Q1 2021

May 17, 2021

SELL
$2.69 - $5.25 $90,653 - $176,925
-33,700 Reduced 14.58%
197,500 $537,000
Q4 2020

Feb 03, 2021

SELL
$3.17 - $4.49 $223,485 - $316,545
-70,500 Reduced 23.37%
231,200 $735,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $407,068 - $710,320
136,600 Added 82.74%
301,700 $1.21 Million
Q1 2020

May 06, 2020

BUY
$1.92 - $4.39 $15,552 - $35,559
8,100 Added 5.16%
165,100 $404,000
Q3 2019

Nov 12, 2019

BUY
$2.17 - $3.14 $79,856 - $115,552
36,800 Added 30.62%
157,000 $405,000
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $6,577 - $7,904
2,600 Added 2.21%
120,200 $361,000
Q1 2019

May 13, 2019

BUY
$2.51 - $3.73 $67,268 - $99,964
26,800 Added 29.52%
117,600 $349,000
Q4 2018

Feb 11, 2019

BUY
$1.59 - $2.66 $60,102 - $100,548
37,800 Added 71.32%
90,800 $216,000
Q3 2017

Nov 01, 2017

BUY
$3.48 - $4.44 $184,440 - $235,320
53,000
53,000 $234,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.